Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.21
+0.11 (1.30%)
Feb 5, 2026, 4:00 PM EST - Market closed
Bioventus Revenue
Bioventus had revenue of $138.65M in the quarter ending September 27, 2025, a decrease of -0.23%. This brings the company's revenue in the last twelve months to $563.83M, up 1.58% year-over-year. In the year 2024, Bioventus had annual revenue of $573.28M with 11.89% growth.
Revenue (ttm)
$563.83M
Revenue Growth
+1.58%
P/S Ratio
0.96
Revenue / Employee
$593,504
Employees
950
Market Cap
549.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 573.28M | 60.94M | 11.89% |
| Dec 31, 2023 | 512.35M | 228.00K | 0.04% |
| Dec 31, 2022 | 512.12M | 81.22M | 18.85% |
| Dec 31, 2021 | 430.90M | 109.74M | 34.17% |
| Dec 31, 2020 | 321.16M | -18.98M | -5.58% |
| Dec 31, 2019 | 340.14M | 20.96M | 6.57% |
| Dec 31, 2018 | 319.18M | 65.53M | 25.83% |
| Dec 31, 2015 | 253.65M | 10.76M | 4.43% |
| Dec 31, 2014 | 242.89M | 10.52M | 4.53% |
| Dec 31, 2013 | 232.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 844.60M |
| Orthofix Medical | 818.06M |
| Avanos Medical | 699.90M |
| Tactile Systems Technology | 311.51M |
| Cytek Biosciences | 196.83M |
| SI-BONE | 193.58M |
| Standard BioTools | 169.74M |
| Pacific Biosciences of California | 154.58M |
BVS News
- 22 days ago - Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 2 months ago - Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Bioventus Inc. (BVS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Bioventus Reports Third Quarter Financial Results - GlobeNewsWire
- 3 months ago - Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 - GlobeNewsWire
- 3 months ago - Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire